Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
07/2004
07/13/2004US6762025 Single-molecule selection methods and compositions therefrom
07/13/2004US6762023 Methods for identifying individuals at risk of developing osteoporosis
07/13/2004US6762019 Use in activated slides for making microarrays of nucleic acids; monomers with pendant epoxy groups to immobilize biological targets, diluent monomers or polymers, and monomers having a photoreactive group to surface treat the substrate
07/08/2004WO2004057032A1 Methods for identifying functionally related genes and drug targets
07/08/2004WO2004057017A2 Detection of small nucleic acids
07/08/2004WO2004057015A2 Detecting a nucleic acid
07/08/2004WO2004056858A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders
07/08/2004WO2004056312A2 Immunoglobulin variants and uses thereof
07/08/2004WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
07/08/2004WO2004034966A3 Substances for preventing and treating autoimmune diseases
07/08/2004WO2004026931A3 Functionalized materials and methods of using same
07/08/2004WO2003097687A3 Neuroprotective polypeptides and methods of use
07/08/2004WO2003070918A3 Rna interference by modified short interfering nucleic acid
07/08/2004WO2003069306A3 Protein carrier system for therapeutic oligonucleotides
07/08/2004US20040132987 Comprises nucleotide sequences coding cysteine rich polypeptide for use in identifying modulators for prevention and diagnosis of atherosclerosis and fibrotic diseases
07/08/2004US20040132685 Immunostimulatory nucleic acid
07/08/2004US20040132684 Modified oligonucleotides or polynucleotides, with modified pyrimidine base, modified purine base, modified ribose, phosphonate linkages, or phosphorothioate linkages; viral infections, cancer, microbial infection; sustained release
07/08/2004US20040132681 Antisense modulation of beta-site APP-cleaving enzyme 2 expression
07/08/2004US20040132677 Chimeric immunomodulatory compounds and methods of using the same-IV
07/08/2004US20040132660 PRO256 polypeptide; wound healing and anticarcinogenic agents; cardiovascular disorders, atherosclerosis, and cardiac hypertrophy treatment
07/08/2004US20040132181 Trans-splicing mediated photodynamic therapy
07/08/2004US20040132138 Nucleic acid encoding recombinant salmon calcitonin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith
07/08/2004US20040132137 Thyroid glycoprotein horomone for treatment and prevention of hyperthyroidism and graves' disease
07/08/2004US20040132136 Comprises viricidal polypeptide for prevention and treatment of viral diseases; antiproliferative agents
07/08/2004US20040132097 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors
07/08/2004US20040132081 DNA chip and its preparation
07/08/2004US20040132072 Dispersion of carbon nanotubles by nucleic acids
07/08/2004US20040132067 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
07/08/2004US20040132065 Promoter sequences for corticotropin releasing-factor binding protein and use thereof
07/08/2004US20040132063 Antisense modulation of microsomal prostaglandin E2 synthase expression
07/08/2004US20040132061 Dual-purpose primers and probes for providing enhanced hybridization assays by disruption of secondary structure formation
07/08/2004US20040132048 Characterizing methylation pattern of a cell, tissue or organism via providing uniform population of randomly cleaved or sheared DNA comprised methylated and unmethylated nucleotides, separate sequences on methyl binding column and quantify
07/08/2004US20040132047 Methods for detection of genetic alterations associated with cancer
07/08/2004US20040132043 Proteins Associated with cell growth, differentiation, and death
07/08/2004US20040132029 Method of error reduction in nucleic acid populations
07/08/2004US20040132014 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
07/08/2004US20040132012 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases
07/08/2004US20040131639 Novel recombinant tryptophan mutants of influenza
07/08/2004US20040131542 Reversal immobilization to ion exchanger
07/08/2004DE10259714A1 Method for identifying the polled genotype in cattle, useful in breeding programs, comprises detecting any of seven new microsatellite markers, also new oligonucleotides
07/08/2004DE10259374A1 Carboxamid-substituierte Farbstoffe für analytische Anwendungen Carboxamide-substituted dyes for analytical applications
07/08/2004CA2847588A1 Detection of small nucleic acids
07/08/2004CA2510381A1 Detection of small nucleic acids
07/08/2004CA2508709A1 Methods for identifying functionally related genes and drug targets
07/08/2004CA2507898A1 Immunoglobulin variants and uses thereof
07/07/2004EP1435389A1 Method of evaluating efficacy of nucleic acid therapy
07/07/2004EP1434882A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes
07/07/2004EP1434879A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
07/07/2004EP1434878A2 Nucleic acid constructs capable of high efficiency delivery of polynucleotides into dna containing organelles and methods of utilizing same
07/07/2004EP1434785A2 Protein modification and maintenance molecules
07/07/2004CN1510139A Human auricular fibrillation pathogenic gene, encoding protein and use thereof
07/07/2004CN1510138A Human liver cancer related gene, encoded product and use thereof
07/07/2004CN1510137A Gene identification
07/07/2004CN1510051A Polypeptide-human cytochrome C oxidase COII protein9 and polynucleotide for encoding said polypeptide
07/07/2004CN1510050A Polypeptide-human ribosome L39 protein 9 and polynucleotide for encoding said polypeptide
07/07/2004CN1510049A Polypeptide-human DBH and PAM20, polynucleotide for encoding said polypeptide
07/07/2004CN1510048A Polypeptide-human ribosomal S9 protein 26 and polynucleotide for encoding said polypeptide
07/07/2004CN1510047A Polypeptide-human guanine mutual change factor 12 and polynucleotide for encoding said polypeptide
07/07/2004CN1510046A Polypeptide-human mitochondrial carrier 14 and polynucleotide for encoding said polypeptide
07/07/2004CN1510045A Polypepetide-human Kringle protein 8 and polynucleotide for encoding said polypeptide
07/07/2004CN1510044A Polypeptide-human beta-transductor 41 and polynucleotide for encoding said polypeptide
07/07/2004CN1510043A Polypeptide-human mitochondrial carrier 30 and polynucleotide for coding this polypeptide
07/07/2004CN1510042A Polypeptide-Human PAX protein 12 and polynucleotide for coding this polypeptide
07/07/2004CN1510041A Polypeptide-human bromo structural protein 9 and polynucleotide for encoding said poly peplide
07/07/2004CN1510039A Anti-CD 20 embedded antibody mutant gene and its use
07/07/2004CN1156583C Parallel ligand index concentration system generating method
07/06/2004US6759532 Extraction of nucleotide sequences from fish; obtain fish semen, disrupt semen, incubate with alkaline solution, incubate with ethanol, precipate nucleotide sequences
07/06/2004US6759513 Death domain containing receptors
07/06/2004US6759392 Inhibiting angiogenesis; using such as 2'-nh2- modified sequence 101-165
07/06/2004US6759219 Comprises coexpression of polyhydroxyalkanoic acid synthase (via alcaligenes) and fatty acid acyl-coa transferase/ synthetase (via clostridium)
07/06/2004US6759199 Nanoparticles having oligonucleotides attached thereto and uses therefor
07/06/2004US6759192 Polymorphic markers of prostate carcinoma tumor antigen-1(PCTA-1)
07/06/2004CA2071510C 2' modified oligonucleotides
07/01/2004WO2004055646A2 Method for profiling and identifying persons by using data samples
07/01/2004WO2004055199A2 A biological sample storage device and method for biological sample contamination testing
07/01/2004WO2004055198A2 Device and method for in-line blood testing using biochips
07/01/2004WO2004055196A2 Method for identifying risk of breast cancer and treatments thereof
07/01/2004WO2004055162A2 Modulation of endothelial lipase expression
07/01/2004WO2004055160A2 Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry
07/01/2004WO2004055159A2 Identification of oligonucleotides for the capture, detection and quantitation of west nile virus
07/01/2004WO2004055117A2 Carboxamide-substituted dyes for analytical applications
07/01/2004WO2004055038A1 Diagnostic test for attention deficit hyperactivity disorder
07/01/2004WO2004055037A2 Process for purifying oligonucleotide synthons
07/01/2004WO2004055036A1 Process for the preparation of oligonucleotides
07/01/2004WO2004054512A2 Therapeutic retroviral vectors for gene therapy
07/01/2004WO2004054502A2 Modulation of tek expression
07/01/2004WO2004054436A2 Calcium-independent phospholipase a2 induces ischemic ventricular arrhythmias and decreases infarction size
07/01/2004WO2004048397A3 Detectable labeled nucleoside analogs and methods of use thereof
07/01/2004WO2004036184A3 Method for drying dye-terminator sequencing reagents
07/01/2004WO2004015126A3 Antisense modulation of edg1 expression
07/01/2004WO2004013606A3 Species specific dna detection
07/01/2004WO2004003511A3 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
07/01/2004WO2004001001A3 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
07/01/2004WO2003097666A3 Use of gastrin releasing peptide (grp) and its receptor in cancer screening
07/01/2004WO2003092582A3 Chimeric ebola virus envelopes and uses therefor
07/01/2004WO2003091386A3 A new family of picornaviruses
07/01/2004WO2003057822A9 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
07/01/2004WO2003054214A3 Tsunami chain reaction - geometric dna amplification
07/01/2004US20040127696 Growth differentiation factor-7
07/01/2004US20040127446 Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication